Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
32mg Pre-filled research pen with 32mg of Retatrutide, a triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors
These agents include semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and tirzepatide (Mounjaro, Zepbound), which also targets the glucose-dependent insulinotropic polypeptide (GIP) receptor
Renovo Health and Beauty is proud to offer Rybelsus as part of our comprehensive weight-loss and wellness programs, providing you with professional guidance and support throughout your journey
PMID: 20736442, PMCID: PMC3027304, DOI: 10.1161/circoutcomes.110.957613
US$ 23.38
US$ 26.20
US$ 20.30
US$ 25.58
